Effect Of Smoking Cessation On Serum Apolipoprotein A-I And A-Ii Concentrations

References

• Miller G J, Miller N E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1975; i: 16–19
   Google Scholar
• Kannel W B, Schatzkin A. Risk factor analysis. Prog Card Dis 1983; 26: 309–22
   Web of Science ®Google Scholar
• Arntzenius A C, Van Gent C M, Van Der Voort H, Stegerhoek C I, Styblo K. Reduced high-density lipoprotein in women aged 40–41 using oral contraceptives. Lancet 1978; i: 1221–3
   Google Scholar
• Garrison R J, Kannel W B, Feinleib M, Castelli W P, McNamara P M, Padgett S J. Cigarette smoking and HDL cholesterol. Atherosclerosis. 1978; 30: 17–25
   PubMed Web of Science ®Google Scholar
• Criqui M H, Wallace R B, Heiss G, Mishkel M, Schonfeld G, Jones G TL. Cigarette smoking and plasma high-density lipoprotein cholesterol. Circulation 1980; 62(Suppl IV)1V-70–IV-76
   Google Scholar
• Taylor K G, Carter T J, Valente A J, Wright A D, Smith J H, Matthews K A. Sex differences in the relationships between obesity alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population. Atherosclerosis 1981; 38: 11–18
   PubMed Web of Science ®Google Scholar
• Stamford B A, Matter S, Fell R D, Sady S, Papanek P, Cresanta M. Cigarette smoking exercise and high density lipoprotein cholesterol. Atherosclerosis 1984; 52: 73–83
   PubMedGoogle Scholar
• Assmann G, Schulte H, Schriewer H. The effects of cigarette smoking on serum levels of HDL cholesterol and HDL apolipoprotein A-I. J Clin Chem Clin Biochem 1984; 22: 397–402
   PubMedGoogle Scholar
• Van Gent C M, Van Der Voort H, Hessell L W. High-density lipoprotein cholesterol monthly variation and association with cardiovascular risk factors in 1000 forty-year-old Dutch citizens. Clin Chim Acta 1978; 88: 155–62
   PubMed Web of Science ®Google Scholar
• Bradley D D, Wingerd J, Petitti D B, Krauss R M, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. New Engl J Med 1978; 299: 17–20
   PubMed Web of Science ®Google Scholar
• Gulbrandsen C L, Morton N E, Rhoads G G, Kagan A, Lew R. Behavioral social and physiological determinants of lipoprotein concentrations. Social Biology 1977; 24: 289–93
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Medalie J H. Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. Amer J Epidemiol 1977; 105: 75–86
   PubMed Web of Science ®Google Scholar
• Hulley S B, Cohen R, Widdowson G. Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention. JAMA 1977; 238: 2269–71
   PubMed Web of Science ®Google Scholar
• Stubbe I, Eskilsson H, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. Br Med J 1982; 284: 1511–13
   PubMed Web of Science ®Google Scholar
• Rabkin S W. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A controlled trial. Atherosclerosis 1984; 53: 173–84
   PubMed Web of Science ®Google Scholar
• Phillips N R, Havel R J, Kane J P. Serum apolipoprotein A-I levels. Relationship to lipoprotein lipid levels and selected demographic variables. Amer J Epidemiol 1982; 116: 302–13
   PubMedGoogle Scholar
• Fortmann S P, Haskell W L, Williams P T. Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Amer J Epidemiol 1986; 124: 706–10
   PubMed Web of Science ®Google Scholar
• Berg K, Borresen A L, Dahlen G. Effect of smoking on serum levels of HDL apoproteins. Atherosclerosis 1979; 34: 339–43
   PubMedGoogle Scholar
• Avogaro P, Bittolo Bon G, Cazzolato G, Quinci G B. Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet 1979; i: 901–3
   Google Scholar
• Brunzell J D, Sniderman A D, Albers J J, Kwiterovich P O, Jr. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984; 4: 79–83
   PubMedGoogle Scholar
• Puddey I B, Vandongen R, Beilin L J, English D R, Ukich A W. The effect of stopping smoking on blood pressure. A controlled trial. J Chronic Dis 1985; 38: 483–93
   PubMedGoogle Scholar
• Nicoll A, Miller N E, Lewis B. High-density lipoprotein metabolism. Advances in Lipid Research 1980; 17: 53–106
   PubMedGoogle Scholar
• Armstrong B K. Workshop on methods of measurement of alcohol consumption. Community Health Studies 1978; 2: 117–88
   Google Scholar
• Burstein M, Samaille J. Rapid determination of cholesterol bound to α- and β-lipoproteins of serum (France). Clin Chim Acta 1960; 5: 609
   PubMed Web of Science ®Google Scholar
• Butts W C, Kuehnemen M, Widdowson G M. Automated method for determining serum thiocyanate to distinguish smokers from non-smokers. Clin Chem 1974; 20: 1344–8
   PubMed Web of Science ®Google Scholar
• Nie N H, Hull C H, Jenkins J G, Steibrenner K, Bent D H. Statistical package for the social sciences. 2nd ed. McGraw-Hill, New York, NY 1974
   Google Scholar
• Kottke B A, Zinsmeister A R, Homes D R, Jr, Kneller R W, Hallaway B J, Mao S JT. Apolipoproteins and coronary artery disease. Mayo Clinics Proceedings 1986; 61: 313–20
   PubMed Web of Science ®Google Scholar
• Kukita H, Hamada M, Hiwada K, Kokubu T. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hyper-triglyceridemic male patients with and without coronary artery disease. Atherosclerosis 1985; 55: 143–9
   PubMedGoogle Scholar
• Fager G, Wiklund O, Olofsson S O, Wilhelmsen L, Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis 1981; 1: 273–9
   PubMedGoogle Scholar
• Karvonen M, Orma E, Keys A, Finzana F. Cigarette smoking serum-cholesterol blood-pressure and body fatness. Lancet 1959; i: 492–4
   Google Scholar
• Hjermann I, Helgeland A, Holme I, Lund-Larsen P G, Leren P. The intercorrelation of serum cholesterol, cigarette smoking and body weight. Acta Medica Scandinavia 1976; 200: 479–85
   PubMedGoogle Scholar
• Gordon T, Kannel W B, Dawber T R, McGee D. Changes associated with quitting cigarette smoking. Amer Heart J 1975; 90: 302–8
   Google Scholar
• Stamford B A, Matter S, Fell R D, Papanek P. Effects of smoking cessation on weight gain, metabolism rate, caloric consumption, and blood lipids. Amer J Clin Nutr 1986; 43: 486–94
   PubMed Web of Science ®Google Scholar
• Quensel M, Soderstrom A, Agardh C D, Nilsson-Ehle P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis 1989; 75: 189–93
   PubMedGoogle Scholar
• Topping D L. Metabolic effects of carbon monoxide in relation to atherogenesis. Atherosclerosis 1977; 26: 129–37
   PubMed Web of Science ®Google Scholar
• Hegarty K M, Turgiss E, Mulligan J J, Cluette J E, Kew R R, Stack D J, Hojnacki J L. Effect of cigarette smoking on high density lipoprotein phospholipids. Biochem Biophys Res Comm 1984; 104: 212–9
   Google Scholar
• Mulligan J J, Hognacki J L, Cluette J E, Kew R R, Stack D J, Nicolosi R J, Flanagan S. Cigarette smoke-induced depression in LCAT activity. Exp Mol Pathol 1981; 35: 25–35
   PubMedGoogle Scholar
• Glomset J A. High-density lipoproteins in human health and disease. Advances in Internal Med 1980; 25: 91–116
   PubMedGoogle Scholar
• Albers J J, Bergelin R O, Adolphson J L, Wahl P W. Population-based reference values for lecithin-cholesterol acyltransferase LCAT. Atherosclerosis 1982; 43: 369–79
   PubMedGoogle Scholar
• Haffner S M, Applebaum-Bowden D, Wahl P W, Hoover J J, Warnick G R, Albers J J, Hassard W R. Epidemiological correlates of high density lipoprotein subfraction apolipoproteins A-I A-Il and D and lecithin cholesterol acyltransferase. Effects of smoking, alcohol and adiposity. Arteriosclerosis 1985; 5: 169–77
   PubMedGoogle Scholar
• Cryer P E, Haymond M W, Santiago J V, Shah S D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. New Engl J Med 1976; 295: 573–7
   PubMed Web of Science ®Google Scholar
• Nikkila E A. Metabolic and endocrine control of plasma high density lipoprotein concentration. High Density Lipoproteins and Atherosclerosis, A M Gotto, Jr, N E Miller, M F Oliver. Elsevier/North Holland Biomedical Press, Amsterdam 1978; 177–92
   Google Scholar
• Richmond W, Seviour P W, Teal T K, Elkeles R S. Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J 1987; 295: 246–7
   PubMedGoogle Scholar
• Gidez L I, Eder H A. The clinical significance of plasma high-density lipoproteins. Clinical and Metabolic Aspects of High-density Lipoproteins Metabolic Aspects of Cardiovascular Disease (3), N E Miller, G J Miller. Elsevier, Amsterdam 1984; 415–70
   Google Scholar
• Carney R M, Goldberg A P. Weight gain after cessation of cigarette smoking. A possible role for adipose-tissue lipoprotein lipase. New Engl J Med 1984; 310: 614–6
   PubMedGoogle Scholar
• Barrett-Connor E, Khaw K T. Cigarette smoking and increased central adiposity. Ann Intern Med 1989; 111: 783–7
   PubMed Web of Science ®Google Scholar
• Ostlund R E, Jr, Staten M, Kohrt W M, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL, cholesterol level in older subjects. New Engl J Med 1990; 322: 229–34
   PubMed Web of Science ®Google Scholar